title: Current and emerging pharmacological treatments for sarcoidosis: a review.
abstract: The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short period of time. However, because sarcoidosis is often a chronic condition, long-term treatment with corticosteroids may cause significant toxicity. Therefore, corticosteroid sparing agents are often indicated in patients requiring chronic therapy. This review outlines the indications for treatment, corticosteroid treatment, and corticosteroid sparing treatments for sarcoidosis.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY 12208, USA.
authors.forename: Scott H
authors.initials: SH
authors.lastname: Beegle
authors.forename: Kerry
authors.initials: K
authors.lastname: Barba
authors.forename: Romel
authors.initials: R
authors.lastname: Gobunsuy
authors.forename: Marc A
authors.initials: MA
authors.lastname: Judson
mesh_terms: D002908:Chronic Disease; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012507:Sarcoidosis / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
chemical_list: D005938:Glucocorticoids
keywords: corticosteroids; drugs; extrapulmonary sarcoidosis; pulmonary sarcoidosis; treatment